IDEXX Laboratories Inc (NASDAQ:IDXX)

200.76
Delayed Data
As of May 18
 +5.17 / +2.64%
Today’s Change
146.09
Today|||52-Week Range
217.89
+28.38%
Year-to-Date

Today’s Trading

Previous close195.59
Today’s open195.87
Day’s range195.15 - 201.25
Volume539,076
Average volume (3 months)543,649
Market cap$18.3B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+20.49%
Earnings growth (this year)+26.86%
Earnings growth (next 5 years)+18.71%
Revenue growth (last year)+10.91%
P/E ratio63.1
Price/Sales7.11
Price/Book--

Competitors

----
NEOGNeogen Corp-0.01-0.01%
----
MYGNMyriad Genetics Inc+0.44+1.26%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$1.20
Annual revenue (last year)$2.0B
Annual profit (last year)$263.1M
Net profit margin13.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Jonathan W. Ayers
Chief Financial Officer, Treasurer &
Executive VP
Brian P. McKeon
Corporate headquarters
Westbrook, Maine

Forecasts